D. Mccormick et al., Variation in length of hospital stay in patients with community-acquired pneumonia: Are shorter stays associated with worse medical outcomes?, AM J MED, 107(1), 1999, pp. 5-12
Citations number
27
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
PURPOSE: To assess the variation in length of stay for patients hospitalize
d with community-acquired pneumonia and to determine whether patients who a
re treated in hospitals with shorter mean stays have worse medical outcomes
.
SUBJECTS AND METHODS: We prospectively studied a cohort of 1,188 adult pati
ents with community-acquired pneumonia who had been admitted to one communi
ty and three university teaching hospitals. We compared patients' mean leng
th of stay, mortality, hospital readmission, return to usual activities, re
turn to work, and pneumonia-related symptoms among the four study hospitals
. All outcomes were adjusted for baseline differences in severity of illnes
s and comorbidity.
RESULTS: Adjusted interhospital differences in mean length of stay ranged f
rom 0.9 to 2.3 days (P <0.001). When the risk of each medical outcome was c
ompared between patients admitted to the hospital with the shortest length
of stay and those admitted to longer stay hospitals, there were no differen
ces in mortality [relative risk (RR) = 0.7; 95% CI, 0.3 to 1.7], hospital r
eadmission (RR = 0.8; 95% CI, 0.5 to 1.2), return to usual activities (RR =
1.1; 95% CI, 0.9 to 1.3), or return to work (RR = 1.2; 95% CI, 0.8 to 2.0)
during the first 14 days after discharge, or in the mean number of pneumon
ia-related symptoms 30 days after admission (P = 0.54).
CONCLUSIONS: We observed substantial interhospital variation in the lengths
of stay for patients hospitalized with community-acquired pneumonia. The f
inding that medical outcomes were similar in patients admitted to the hospi
tal with the shortest length of stay and those admitted to hospitals with l
onger mean lengths of stay suggests that hospitals with longer stays may be
able to reduce the mean duration of hospitalization for this disease witho
ut adversely affecting patient outcomes. (C) 1999 by Excerpta Medica, Inc.